FINWIRES · TerminalLIVE
FINWIRES

Leerink Partners Upgrades Edwards Lifesciences to Outperform From Market Perform, Adjusts PT to $101 From $87

By

Edwards Lifesciences (EW) has an average rating of overweight and mean price target of $100.98, according to analysts polled by FactSet.

What else is happening in Research?